Cargando…
Plasma-glycated CD59 as an early biomarker for gestational diabetes mellitus: prospective cohort study protocol
INTRODUCTION: The significant maternal and neonatal outcomes of gestational diabetes mellitus (GDM) make it a major public health concern. Mothers with GDM are at greater risk of pregnancy complications and their offspring are at higher risk of diabetes and obesity. Currently, GDM is diagnosed with...
Autores principales: | Andrews, Chloe, Toth-Castillo, Michelle, Aktas, Huseyin, Fernandez, Miguel-Angel Luque, Wong, Steven Koon, Sen, Sarbattama, Halperin, Jose |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021770/ https://www.ncbi.nlm.nih.gov/pubmed/35443950 http://dx.doi.org/10.1136/bmjopen-2021-054773 |
Ejemplares similares
-
The utility of first trimester plasma glycated CD59 (pGCD59) in predicting gestational diabetes mellitus: A prospective study of non-diabetic pregnant women in Ireland
por: Bogdanet, Delia, et al.
Publicado: (2022) -
Plasma Glycated CD59, a Novel Biomarker for Detection of Pregnancy-Induced Glucose Intolerance
por: Ghosh, Pamela, et al.
Publicado: (2017) -
The Diagnostic Accuracy of Second Trimester Plasma Glycated CD59 (pGCD59) to Identify Women with Gestational Diabetes Mellitus Based on the 75 g OGTT Using the WHO Criteria: A Prospective Study of Non-Diabetic Pregnant Women in Ireland
por: Bogdanet, Delia, et al.
Publicado: (2022) -
Correlation between Glycated Hemoglobin and Triglyceride Level in Type 2 Diabetes Mellitus
por: Naqvi, Syeda, et al.
Publicado: (2017) -
Glycosylated haemoglobin for screening and diagnosis of gestational diabetes mellitus
por: Khalafallah, Alhossain, et al.
Publicado: (2016)